Open access peer-reviewed chapter

Epidemiology of Leishmaniasis

Written By

Stephen Kyari

Submitted: 15 August 2022 Reviewed: 12 February 2023 Published: 24 April 2024

DOI: 10.5772/intechopen.110490

From the Edited Volume

Leishmania Parasites - Epidemiology, Immunopathology and Hosts

Edited by Fernando Almeida-Souza, Flávia de Oliveira Cardoso, Ana Lucia Abreu-Silva and Kátia da Silva Calabrese

Chapter metrics overview

37 Chapter Downloads

View Full Metrics

Abstract

A zoonotic illness of importance to the public’s health is leishmaniasis. Leishmania donovani, Leishmania tropica, Leishmania major, Leishmania infantum, Leishmania chagasi, Leishmania mexican, and Leishmania braziliensis are the most recognised and widely distributed leishmania parasite species, and they are also the ones that cause the disease. On every continent and in more than 90 countries, the disease is present, however it appears to be absent from Australia. The disease is spread by Phlebotomus sandflies, and people, rodents, and other domestic animals act as reservoirs and unintentional hosts. Cutaneous leishmaniasis, diffuse cutaneous leishmaniasis, mucocutaneous leishmaniasis, and visceral leishmaniasis are the four ways the illness can present. The spread of the disease, as well as its appearance and reemergence, are caused by risk factors include regional warfare and wars, political instability, migration of people, substandard housing, climate, vegetation cover, p7oor socioeconomic standard of life, and lack of access to quality medical care. To eradicate the disease, particularly in poor nations where it is still a threat, there is a need for increased public education, government involvement, proper surveillance, and disease reporting.

Keywords

  • epidemiology
  • distribution
  • risk factors
  • Phlebotomus sandfly
  • leishmaniasis

1. Introduction

Leishmaniasis is a disease that is caused by the parasite Leishmania; comprising of at least 20 species that affect humans. The parasite is primarily transmitted by the sand flies that belongs to the Phlebotomus in the old world and Lutzomyia in the new world; however, other principal hosts are rodents such as Rhombomys opimus, Tatera indica, Meriones hurrianae, and Meriones libycus gerbils which are of the Zoonotic cutaneous leishmaniasis (ZCL) [1, 2, 3, 4, 5]. The disease is associated with and limited by the geographical distribution of its sand fly vectors. Fifteen geographical entities have been classified worldwide, of which 13 zoonotic in nature. In recent years, there have been significant increase in the number of regions becoming Leishmania-endemic, accompanied with an increased number of animal and human cases. These parasites have been reported to be maintained and circulated in mammals with each species having a specific reservoir host [6]. The clinical spectrum of the disease in humans can be asymptomatic infections in some individual and can result in high mortality, which depends on the form of the disease and can be categorised into three (4) namely; visceral leishmaniasis (VL), cutaneous leishmaniasis (CL), diffuse cutaneous leishmaniasis (DCL) and mucocutaneous leishmaniasis (MCL). In dogs, Leishmania infantum and Lieshmania chagasi are now regarded as synonyms and are the species known to be responsible for chronic visceral-cutaneous disease in this host (canine leishmaniosis). Asymptomatic infections occur in dogs and other canines thereby maintaining the presence of the parasite in endemic regions [6]. The ability of the host macrophages to effectively destroy the parasite is as a result of host- parasite interaction which is responsible for clinical appearance. Leishmaniasis is classified as a prominent neglected disease of the tropics due to the number of death per year (40,000) with a global distribution with Indian sub-continent having the highest number of cases followed by Bangladesh, Sudan, South Sudan, Ethiopia, and Brazil [7, 8].

1.1 Cutaneous leishmaniasis

The aetiological agent responsible for cutaneous leishmaniasis are as follows: Leishmania tropica, Leishmania major, and Leishmania aethiopica, also known as old- and new-world leishmania species, are found in southern Europe, the Middle East, Asia, and Africa, respectively. These species include Leishmania guyanensis, L. viannia braziliensis, L. viannia amazonesis, L. viannia panamensis, and the Leishmania mexicana complex (Latin America). Skin ulcers on the exposed body parts, such as the face, arms, and legs, as well as lesions that leave the patient permanently disfigured and prone to social judgement, are the hallmarks of cutaneous leishmaniasis. The incubation time is roughly 2 to 6 weeks [9]; cases of up to 3 years have been documented for Old World cutaneous leishmaniasis [10], whereas the incubation period for New World cutaneous leishmaniasis is typically 2 to 8 weeks [11]. Over 85% of newly discovered CL cases in 2018 that were reported to the WHO originated in Afghanistan, Algeria, Bolivia, Brazil, Colombia, Iran, Iraq, Pakistan, Syria, and Tunisia, while over 95% of newly discovered LV cases originated in Brazil, China, Ethiopia, India, Iraq, Kenya, Nepal, Somalia, and Sudan. Finally, four nations—Brazil, Bolivia, Ethiopia, and Peru—reported almost 90% of all new cases of mucocutaneous leishmaniasis (MCL) [12].

1.2 Mucocutaneous leishmaniasis

Leishmania viannia braziliensis, leishmania viannia amazonesis, leishmania viannia panamensis, and leishmania viannia guyanesis are the leishmania species that cause mucocutaneous leishmaniasis. The progression of this illness is controlled by parasite virulence and host cell mediated immunity. The condition starts with erythema and ulceration of the nose, which progresses to continuous degradation of the cartilage in the upper airway and facial structures, oronaso-pharyngeal mucosa, disfigurement, and obstruction of the airway [13].

1.3 Diffuse cutaneous leishmaniasis

Even in nations where leishmaniasis is endemic, diffuse cutaneous leishmaniasis is a rare manifestation of the illness. Leishmania mexicana and Leishmania aethiopica are the parasites that cause this type of leishmaniasis. A small, painless bump at the site of the innoculation causes spreading, non-ulcerating macules, nodules, and plaques that range in colour from erythematous to violet. The face, upper and lower limbs, and buttocks are the area most commonly affected [14, 15].

1.4 Visceral leishmaniasis

Leishmania donovani is the cause of visceral leishmaniasis. The most serious type of the disease, which affects internal organs like the spleen and liver and can be deadly if neglected, is Kala-azar cutaneous leishmaniasis, which ranges from hypopigmented macules to infiltrating papules [16]. The incubation period ranges from three to eight months [17]; symptoms include fever, weight loss, hepatosplenomegaly, lymphadenopathy, pancytopenia, and hypergammaglobulinaemia; skin pigmentation may also be present [18]; “kala azar,” also known as black disease, may be asymptomatic and self-resolving, but typically has a chronic course and can be fatal with or without treatment [19]; death typically results due to bacterial infections. In the Indian subcontinent, Bangladesh, India, and Nepal are the most severely affected and account for 28% of cases, while Brazil contributes 20%. The three eco-epidemiological hotspots where VL has been identified are East Africa, where countries like Ethiopia, Kenya, Somalia, South Sudan, Sudan, and Uganda contribute 45% of global cases (Figure 1 [20] and Table 1 [21, 22, 23]) [24].

Figure 1.

Shows the geographical distribution pattern of leishmaniasis [20].

Leishmania species
Old world cutaneous leishmaniasisLeishmania tropica, Leishmania major, Leishmania infantum, Leishmania aetheiopica
New world cutaneous leishmaniasisLeishmania vianna subgenous (e.g., Leishmania vianna braziliensis, Leishmania vianna panamensis, Leishmania vianna guyanensis, Leishmania vianna peruviana, Leishmania amazonensis) and Leishmania Mexicana complex

Table 1.

Shows old world and new world cutaneous leishmaniasis [21, 22, 23].

Advertisement

2. Main text

2.1 Distribution pattern, vector and causative agents of Leishmaniasis

Leishmaniasis is endemic in several parts of Africa. In North Africa, nations including Morocco, Algeria, Tunisia, Libya, and Egypt have recorded numerous instances of the disease, with cutaneous and visceral leishmaniasis being the most prevalent types [25]. Important species that are spread by the phlebotomus sand fly include L. major, L. tropica, L. infantum, and Labrus donovani. L. major is the main cause of cutaneous leishmaniasis, with L. tropica and L. infantum playing a less significant role. Visceral leishmaniasis (VL) has been linked to L. donovani, L. infantum, and infrequently L. tropica. Zoonotic cutaneous leishmaniasis (ZCL) and Anthropogenic cutaneous leishmaniasis (ACL) are the two kinds of cutaneous leishmaniasis seen in this region [6, 26, 27, 28]; with ZCL being caused by L. major and transmitted by mainly by P. papatasi, P. duboscqi and P. salehi with P. papatasi considered among the most widespread invasive sandflies species in these regions and the also has a worldwide distribution; Psammomys obesus, Meriones libycus, Meriones shawi, Nesokia indica, and Rhombomys opimus rodents also transmit the disease, while ACL is caused by L. tropica is transmitted by P. sergenti and gundi and hyraxes and Leishmania killicki with dogs also serving as accidental host in some cases [6, 29, 30, 31, 32, 33]. Additionally, there are two types of visceral leishmaniasis: (ZVL). Anthropogenic visceral leishmaniasis (AVL), which is caused by L. infantum, is primarily zoonotic, with candida serving as the principal reservoir and humans serving as unintentional hosts [34, 35, 36]. The most common form of leishmaniasis in Morocco, Algeria, and Lybia is cutaneous leishmaniasis, which is caused by the L. tropica species [37, 38, 39, 40]. According to reports, L. tropica is a reservoir host in Ethiopia and Chad has noted an upsurge in visceral leishmaniasis in Central Africa [41, 42].

The countries of Sudan, South Sudan, Ethiopia, Kenya, Uganda, and Somalia make up one of the main geographic regions in East Africa most severely affected by VL, where the disease is primarily brought on by Leishmania donovani and, in certain cases, Leishmania infantum [43, 44, 45]. With the confirmation of Phlebotomus orientalis, Phlebotomus martini, Phlebotomus celiae, and Phlebotomus rodhaini as VL vectors [46, 47, 48, 49, 50], man and dogs serve as potential reservoir hosts. Subgenera such as Paraphlebotomus, Synphlebotomus, Larroussius, and Anaphlebotomus have also been reported [51, 52]. In East Africa, children under the age of 15 make up about 65% of VL cases, and having inadequate levels of protein, energy, iron, vitamin A, and zinc increases the risk of VL manifestation [53]. In East Africa, cutaneous and mucosal leishmaniasis have both been attributed to Leishmania donovani [54, 55, 56]. VL has been reported and is prevalent in Kenya, Uganda, and Somalia along their borders; L. donovani and L. infantum are the parasites responsible for the disease [57, 58, 59]. Every year, Sudan reports over two-thirds of the VL cases in East African nations; the majority of these cases are presumed to be caused by L. donovani [60, 61], and recent outbreaks in South Sudan have been linked to over 100,000 fatalities between 1983 and 2005 [62]. It is possible for VL to develop complications that lead to post-kala-azar cutaneous leishmaniasis, which is characterised by a macular or nodular rash that frequently starts at the mouth and is transmitted by P. argentipes and P. orientalis [63].

The disease has also been documented in Cameroon, Burkina Faso, Mauritania, Gambia, Guinea, and Nigeria in West Africa. Lieshmaniasis was originally identified in Niger, then in Nigeria, Senegal, and Mali. Mauritania, Gambia, Senegal, Nigeria, Cameroon, and Ghana are among the countries where CL is endemic and is caused by L. major [64, 65]. The only known case of MCL in the area is in Senegal, while the only instances of VL have been recorded in Togo and Burkina Faso with L. donovani as the causing agent [66]. Rodents including Mastomys erythroleucus, Tatera gambiana, Arvicanthis niloticus, and Mastomys erythroleucus, as well as dogs in Gambia, serve as the reservoir host for L. major. The parasites L. major and L. donovani, which transmit VL and CL in Ghana, Nigeria, and Senegal, respectively, are the most prevalent forms to be recorded together with P. duboscqi and P. rodhaini [66, 67, 68, 69].

Syria has historically been endemic to CL due to L. tropica for centuries and, at one point, had the highest burden of this form of leishmaniasis in the region. Recent research indicates that political unrest, wars, and population migration have contributed to an increase in cases in the Middle East [70]. Due to the influx of migrants, these circumstances have caused outbreaks to be reported in 2012 in other countries including Lebanon, which have seen a rise in the number of cases recorded [71, 72]. L. tropica has also been claimed to be endemic in Israel and the Philistines, while the cycle of transmission is not completely understood. With a widespread geographic distribution throughout the region, Phlebotomus (Paraphlebotomus) sergenti has been identified as the primary vector of L. tropica [73, 74, 75]. Phlebotomus arabicus and Phlebotomus similis have also been documented. Leishmania major has reportedly been linked to CL in Southern Israel; this type of the illness is self-healing but makes the patient anxious. The reservoir host is the obese sand rat Psammomys obesus (Cricetidae: Gerbillinae), and P. obesus and the sand fly Phlebotomus papatasi (Diptera: Psychodidae) serve as the vectors [76]. Leishmania majori, the parasite that causes CL and VL, is the primary carrier of both the disease and its primary vector, P. papatasi. VL is primarily brought on by Leishmania infantum, though L. tropica can also be to blame in some cases. CL comes in two forms: ZCL and ACL, which are caused by L. major and L. tropica, respectively. Rodents are the main reservoir hosts, and some of the more endemic species include Rhombomys (R.) opimus, Meriones libycus, Tatera (T.) indica, and Meriones hurrianae. Phlebotomus papatasi transmits L. major, whereas Phlebotomus sergenti transmits L. tropica [70, 77, 78, 79]. ACL and ZCL are present, L. tropica and L. major are endemic in Saudi Arabia, and CL is declining with fewer instances being reported [80, 81, 82, 83]. The most common kind of leishmaniasis in Iraq is CL, which is caused by the parasites Leishmania tropica and Leishmania major [84, 85, 86]. ACL and ZCL are the two types of CL that are endemic in Pakistan [87]; L. tropica and L. major are the two known forms of the parasite that transmit CL [88, 89, 90]. The frequency of ACL is higher than ZCL in Afghanistan, where L. tropica is known to account for 96 to 98% of CL cases [91]. ACL is said to be endemic in Turkmenistan, with L. major as the causative agent [8].

Countries in Europe, including Greece, have reported occasional cases of CL caused by L. tropica; Phlebotomus sergenti has been identified as the disease’s primary vector and is thought to be responsible for its spread [92]. There have been reports of Phlebotomus tobbi and Phlebotomus perfiliewi as potential L. tropica vectors [93]. Although CL caused by L. tropica has not been documented in Europe, P. sergenti was found in Greek camps where 21 different sand fly species had significant levels of L. tropica infection. The emerging and re-emerging of leishmaniasis in Europe has been attributed to the introduction of exotic Leishmania species or strains via worldwide travelling of humans and domestic dogs; this is also responsible for the spread of visceral and cutaneous leishmaniasis caused by L. infantum and L. tropicai due to their endemicity from the Mediterranean region of Europe to neighbouring temperate areas where there are vectors without disease [90, 94]. A high risk of leishmaniasis spreading to Europe is posed by both zoonotic cutaneous and visceral leishmaniasis caused by L. infantum in the Mediterranean region and anthroponotic cutaneous leishmaniasis caused by L. tropica in Greece. Additionally, the presence of Phlebotomus sandflies without the disease is of public health concern [95]. A retrospective study of leishmaniasis across Europe revealed that cutaneous leishmaniasis was the prevalent form of the disease that occurred in 11 countries followed by visceral and mucosal disease with L. donovani, L. infantum (syn. L. chagasi in New World), L. major, L. amazonensis (syn. L. garnhami), L. Mexicana, L. aethiopica, L. tropica, L. braziliensis, L. peruviana, L. guyanensis, L. panamensis, L. lainsoni, L. naiffi, L. siamensis /Lechytia martiniquensis been the parasites identified and responsible for the disease [96].

In North America, parasite species in the genus Leishmania are responsible for different clinical pathologies of the disease which include VL that is deadly and caused by L. chagasi, as well as MCL, localised Leishmaniasis, diffuse Leishmaniasis; MCL has been reported to be caused by L. brasiliensis, L. panamensis and L. guyanensis; DCL are related to L. m. mexicana, L. amazonensis, L. pifanoi, L. guyanensis, and L. panamensis [97]. Female blood-feeding sand flies of the genus Lutzomyia (Diptera: Psychodidae: Phlebotomidae) are the transmission vector in Mexico, the United States, and Canada; humans are incidental hosts while mammals serve as reservoir hosts; L. mexicana is responsible for the majority of human cases that have been reported [98]. Leishmania infantum, which causes canine visceral leishmaniasis, has been reported in dogs and cats. While cutaneous Leishmania mexicana is endemic to the United States, visceral leishmaniasis is not considered endemic among humans but primarily affects dogs, which are thought to be the reservoir host for humans [99, 100].

Leishmania (Viannia) braziliensis, L. (Viannia) amazonensis, L. (Viannia) guyanensis, and L. Infantum, associated with visceral leishmaniasis, were the four species of Leishmania cases reported in humans in South America. In addition, 28 species of Phlebotominae (23 species of Lutzomyia, 4 species of Brumptomyia, and 1 species of [101]. Both CL and MCL are induced by L. Braziliensis: Lutzomyia neivai, L. Whitmani, L. Cortelezzii complex (L. Cortelezzii, L. Sallesi), L. Migonei, and L. Pessoai, while V is brought on by L. Infantum was L. Longipalpis [102]. However, domestic and wild canids have been well established as the reservoir host of leishmania, with more than 20 species of the parasites being transmitted by the phlebotomine vectors (Diptera, Psychodidae); CL and VL are the two major forms of the disease where Leishmania (Viannia) braziliensis, Leishmania (Leishmania) amazonensis, L. mexicana, L. donovani causes VL in the old world, but L. infantum does so in the new world [103, 104, 105, 106, 107]. In Colombia several species of Leishmania parasites have been reported to infect humans with CL been the major form of the disease followed by MCL and VL; L. braziliensis, L. panamensis and L. guyanensis have been responsible for the outbreaks of CL; other parasites include L. lainsoni, L. amazonensis, L. infantum chagasi, L. Mexicana, L. colombiensis and L. equatoriensis, this country is ranked second only to Brazil in terms of cases of leishmaniasis [108, 109, 110]. In Bolivia, Leishmania (Viannia) lainsoni, Leishmania (Viannia) guyanensis, Leishmania (Viannia) panamensis and Leishmania (Leishmania) amazonensis have been described as a causal agent of Tegumentary leishmaniasis (TL) (CL, MCL, DCL) with transmission also reported to be zoonotic and caused by Nyssomyia neivai, Cortelezzii complex, Evandromyia sallesi, Migonemyia migonei and Micropygomyia quinquefer [111].

The parasite L. donovani, the vector Phlebotomus annandalei, Phlebotomus argentipes sensu stricto, and Phlebotomus glaucus, and the disease CL, MCL, and VL are all endemic throughout Asia [112]. VL, which is indigenous to Nepal and brought on by L. donovani, can occasionally lead to post-Kala-azar cutaneous leishmaniasis [113]. Similar to Kala-azar sickness, VL is chronic in Bangladesh and can lead to it. L. donovani is thought to be the main cause of the illness, while Phlebotomus papatasi is the disease’s vector in Asia [114, 115].

Leishmania donovani is the chronic disease that causes VL on the Indian subcontinent; however, L. tropica or L. infantum, particularly when co-infected with HIV, can also cause the illness; Phlebotomus argentipes is the vector for VL, with humans functioning as reservoir hosts. PKDL does not have an animal reservoir, and transmission is thought to be anthroponotic [116, 117]. VL is also known as kala-azar, which is the Hindi word for “black disease” (Table 2).

Clinical formsLeishmania parasiteGeographical distribution
CLL. major, L. tropica, L. infantum, and Labrus donovani; L. braziliensis: Lutzomyia neivai, Lu. Whitmani, L. Cortelezzii complex (L. Cortelezzii–L. Sallesi), L. Migonei, and L. Pessoai, L. (L.) peruviana, L. lainsoni, L. amazonensis, L. infantum chagasi, L. Mexicana, Leptodactylus colombiensis and L. equatoriensisMorocco, Algeria, Tunisia, Libya, Egypt; Chad; Sudan, South Sudan, Ethiopia, Kenya, Uganda and Somalia; Niger, Nigeria, Senegal and Mali; Cameroon, Burkina Faso, Mauritania, Gambia and Guinea, Ghana; Syria, Lebanon, Israel, Philistines, Iran, Saudi Arabia, Iraq, Pakistan, Afghanistan, Turkmenistan; Greece; United State of America; Bolivia, Brazil, Colombia, Peru; Sri Lanka, China, Nepal Bangladish; India, and
MCLL. viannia braziliensis, L. viannia amazonesis, L. viannia panamensis and L viannia guyanesisSenegal; Colombia; Sri Lanka
DCLL. Mexicana, L. aethiopica, L. amazonensis, L. pifanoi, L. guyanensis, and L. panamensisMexico, United States, and Canada
VLL. donovani, L. infantum, L. tropica, L. chagasiEthiopia, Kenya, Somalia, South Sudan, Sudan, Chad, Togo, Burkina Faso, Cameroon and Uganda; Iran, Bangladesh, Sri Lanka and Nepal; India; Brazil, Argentina, Colombia; India

Table 2.

The table below shows the clinical form of leishmaniasis and their geographical distribution [21, 22, 23].

Advertisement

3. Leishmaniasis and HIV co-infection

There have been reports of leishmania-HIV co-infection in 45 countries in 2021, with Brazil, Ethiopia, and Bihar in India having the highest number of cases [118]. According to a report by the WHO in 2022, people who have leishmaniasis and HIV are at an increased risk of developing full clinical disease, high relapse rates, and mortality rates. Leishmaniasis and HIV co-infection have also been shown to occur in CL and VL [119, 120]. A change in immune response brought on by immunosuppression caused by a low CD4 T-lymphocyte count and the development of immunological activation with cell senescence are two examples of the clinical manifestation of VL [121].

Advertisement

4. Risk factors in the distribution of Leishmaniasis

Conflict, climate (temperature, rainfall, relative humidity, precipitation), physical (geographical barriers), and biotic (distribution and abundance of vertebrate hosts) factors, socioeconomic circumstances, environmental (land degradation, agricultural activities, deforestation due to urbanisation), domestic animals and living standards, immune response of hosts, and conflict have all been linked to the distribution of leishmaniasis [6]. Although no consistent pattern has been identified, civil wars, social unrest, migration, forced population displacement, rainfall, humidity, temperature, soil types and moisture contents, and land cover type are significantly associated with the distribution pattern of these sandflies and contribute to emerging and re-emerging outbreaks [18].

Advertisement

5. Climatic conditions

Leishmaniasis is a disease that is sensitive to climate because variations in temperature, precipitation, and humidity have a significant impact on the life cycles of the parasite’s vectors and reservoir hosts. Climate changes can also affect the distribution, survival, and population of the vectors and reservoir hosts [122]. Sandflies have been reported to be abundant between the months of June and September with P. argentipes being active between this period in India with temperature ranging between 27 and 31°C [123, 124]. Fluctuations in temperature can negatively affect the developmental life cycle of leishmania promastigote in sandflies, which can result in the transmission of the parasite into areas not previously endemic for the disease.

5.1 Vegetation cover

Leishmaniasis outbreaks have been shown to decrease with the improvement of vegetation types that limit rodent growth [125]; it has also been established that areas with thick or dense vegetation cover have a higher risk of leishmaniasis infection and transmission [126]. Forest fragmentation and deforestation have been linked to an increased risk for leishmaniasis.

5.2 Age and gender

Leishmaniasis has been found to affect adults more frequently than children; this could be because younger people are less exposed to the parasites and vectors that cause the disease, especially in rural areas where adults are more engaged in farming and other socioeconomic activities than children are. It has also been found that men are generally more susceptible to infection, though this could vary [127, 128].

5.3 Housing and socio-economic conditions

Poor housing and the lack of good sanitary conditions in terms of waste management, sewage disposal, and drainages in the majority of rural and semi-urban centre provide breeding and resting sites for sandflies, bringing this vector closer to human habitation. These sandflies feed on blood meal. Other good breeding sites for these vectors include cracks and crevices in walls, roofs that are poorly made, and thatched homes [129]. The disease spreads as a result of people moving from rural to urban areas for economic reasons [130, 131, 132].

5.4 Domestic animal breeding

It has been discovered that there may be a significant risk of infection in houses where animals are housed, bred, or live in close proximity to people. This is because some of these animals may act as reservoir hosts for the disease; leishmaniasis, particularly the VL, affects dogs and felines [133].

5.5 Host immune responses and parasite factor

In order for the infection to take hold, promastigotes must infiltrate macrophages and avoid inducing host defences. Additionally, the progression of intracellular infection by amastigotes depends on the preservation of macrophages in an inert, deactivated state. Through cell-mediated immunity and delayed-type hypersensitivity, an immunocompetent host defence system is equipped with and reacts to non-specific innate and antigen-specific acquired mechanisms; these inflammatory responses play a critical role in disease expression and may result in asymptomatic infection and self-healing or may result in clinical manifestation of disease. People with weakened immune systems, such as HIV patients, are more susceptible to infection since their immune systems are unable to defend them against the parasites. The parasite, however, can alter intracellular kinases, phosphatases, signalling pathways, the responsiveness of macrophages to the parasite and secretion of cytokines, as well as dendritic cell and macrophage mechanisms. This allows the parasites in the case of an infection to alter, temper, or hinder with intracellular kinases, phosphatases, signalling pathways, the responsiveness of macrophages to the parasite and secretion of the parasite can also disrupt dendritic cells, which are important for antigen presentation, T-cell co-stimulation, and the effective establishment of acquired Th1 responses [134].

Advertisement

6. Life cycle of leishmania parasite

Leishmania parasites go through two main stages in their life cycle: the extracellular stage in invertebrate hosts and the intracellular stage in vertebrate hosts. The parasite has two primary morphologies: amastigote and promastigote, with the former occurring in vertebrate hosts and the latter in invertebrate hosts. The promastigotes are injected into the host circulation by female sandflies during a blood meal on a vertebrate host; after this inoculation, the promastigotes are phagocytosed by the host macrophages; the macrophage ruptures and releases a large number of amastigotes into circulation. Monocytes and macrophages in the spleen, liver, lymph nodes, bone marrow, and other tissues of reticulo-endothelial cells are invaded by the released amastigotes. The female sandflies then consume free amastigotes from the blood as well as intracellular amastigotes from the monocytes. The promastigotes in the sand fly’s midgut move over a period of 6 to 9 days to its pharynx and buccal cavity, where the sand fly can spread the parasites to a new host after a blood meal [135].

Advertisement

7. The vector for leishmaniasis

Only 21 of the 700 species of sandflies (family Phlebotominae) are known to be disease vectors. The majority of these species belong to the genera Phlebotomus, Sergentomyia, and Lutzomyia; the Lutzomyia group includes species from the old and new worlds. Old-world species are those that can be found in South and Central Asia, the Indian subcontinent, the Middle East, North and East Africa, and Southern Europe; new-world species are those that can be found in Brazil and other Latin American nations, Mexico, and the United States. These fly species are absent from Australia but are indigenous to over 90 other nations and are found on every continent [136]. The following list includes the phlebotomous sandfly species that cause leishmaniasis in the old world. The transmission of L. major, L. tropica, L. infantum, and L. aethiopica is carried out by P. longicuspis, P. papatasi, P. ariasi, P. pedifer, P. duboscqi, P. rhodaini, P. segenti, and P. sergenti. The new world sandfly genus Lutzomyia includes species including L. hartmanni, L. gomezi, L. longipalpis, L. Ayacuchensis, L. Sanguinaria, L. Trapidoire responsible for the transmission of L. infantum, L. vianna equatorensis, L. colombiensis, and L. vianna braziliensis, among others. The Psychodopygus, which includes species like P. panamensis, P. carrerai, and P. amazonensis, is another type of sandfly of significant medical and veterinary significance [42, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144].

Advertisement

8. Conclusions

L. donovani, L. tropica, and L. major are the species that cause infection in Africa, L. tropica, L. major, and Leishmania infantum are the species that cause infection in the Middle East, L. tropica, L. infantum, and Europe, L. mexicana and L. chagasi are the species that cause infection in North America, and Leishmania (Viannia) braziliensis is the species that causes infection in South America. The disease is spread by numerous different species of Phlebotomus sandflies. Risk factors for the disease include climatic factors, vegetation cover, age and gender, housing and socioeconomic circumstances, animal breeding, and host immunity. Additionally, migration of people from other continents has been to blame for the emergence and re-emergence of the disease in Europe where there is civil and regional strife, political instability, and increased disease transmission and dissemination between continents. Obstacles to the quest to eradicate the disease include limited access to health care, a lack of national policy, and the maintenance of such policy, if it exists, particularly in developing nations.

Advertisement

Acknowledgments

Non to be disclosed.

Advertisement

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1. Ahmed K, Abdelkrim BS, Denis S, Samir, El J, Lhoussain H. Geographic distribution of Meriones shawi, Psammomys obesus, and Phlebotomus papatasi the main reservoirs and principal vector of zoonotic cutaneous leishmaniasis in the Middle East and North Africa. Parasite Epidemiology and Control. 2022;17:e00247
  2. 2. Javadian E, Dehestani M, Nadim A, Rassi Y, Tahvildar-Bidruni G, Seyedi-Rashti M, et al. Confirmation of Tatera indica (Rodentia: Gerbilldae) as the main reservoiur host of zoonotic cutaneous leishmaniasis in the west of Iran. Iranian Journal of Public Health. 1998;27(1-2):55-60
  3. 3. Rasi Y, Jalali M, Javadian E, Motazedian MH. Confirmation of Meriones libycus (Rodentia; Gerbillidae) as the main reservoiur host of zoonotic cutaneous leishmaniasis in Arsanjan, Fars Province, south of Iran (1999-2000). Iranian Journal of Public Health. 2001;30(3-4):143-144
  4. 4. Afshar AA, Rassi Y, Sharifi I, Abai M, Oshaghi M, Yaghoobi-Ershadi M, et al. Susceptibility status of Phlebotomus papatasi and P. sergenti (Diptera: Psycholididae) to DDT and deltamethrin in a focus of cutaneous leishmaniasis after earth quake strike in bam, Iran. Iranian Journal of Arthropod-Borne Diseases. 2011;5(2):32 PMCID: PMC3385580. PMID: 22808416
  5. 5. Gholamrezaei M, Mohebali M, Hanaf-Bojd AA, Sedaghat MM, Shirzadi MR. Ecological niche modeling of main reservoir hosts of zoonotic cutaneous leishmaniasis in Iran. Acta Tropica. 2016;160:44-52. DOI: 10.1016/j.actatropica.2016.04.014
  6. 6. Tabbabi A. Review of Leishmaniasis in the Middle East and North Africa. African Health Sciences. 2019;19(1):1329-1337. DOI: 10.4314/ahsv19i1.4
  7. 7. WHO expert committee on the control of the leishmania and World Health Organization (2010) control of leishmaniases: Report of a meeting of the WHO expert committee on the control of leishmaniases Geneva, 22-26 March 2010
  8. 8. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7:e35671. DOI: 10.1371/journal.pone.0035671
  9. 9. Hafza I, Muhammad ZK. Types and treatments of Leishmaniasis. Journal of Scientific and Technical Research. 2022;42(5):34037-34042. DOI: 10.26717/BJSTR.2022.42.006815
  10. 10. Tonio VP, Charles MA. Leishmaniasis. Postgraduate Medical Journal. Feb 2007;83(976):649-657. doi: 10.1136/pgmj.2006.047340corr1
  11. 11. Marsden PD, Nonata RR. Mucocutaneous leishmaniasis—A review of clinical aspects. Revista da Sociedade Brasileira de Medicina Tropical. 1975;9:309-326
  12. 12. Abadías-Granado I, Diago A, Cerro PA, Palma-Ruiz AM, Gilaberte Y. Cutaneous and Mucocutaneous Leishmaniasis. Actas Dermo-Sifiliográficas. 2021;112:601-618
  13. 13. Ahluwalia S, Lawn SD, Kanagalingam J, Grant H, Lockwood DN. Mucocutaneous leishmaniasis: An imported infection among travellers to central and South America. BMJ. 2004;329:842-844
  14. 14. David CV, Craft N. Cutaneous and mucocutaneous leishmaniasis. Dermatologic Therapy. 2009;22(6):491-502
  15. 15. David CR, Llanos-Cuentas EA, Campos P, et al. Spraying houses in the Peruvian Andes with lambda-cyhalothrin protects residents against cutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2012;94:631-636
  16. 16. Mauel J. Vaccination against Leishmania infections. Current Drug Targets - Immune, Endocrine & Metabolic Disorders. 2002;2:201-226
  17. 17. Manson-Bahr PEC, Apted FIC. Leishmaniasis. In: Manson-Bahr PEC, Apted FIC, editors. Manson’s Tropical Diseases. 18th ed. London: Bailliere Tindall; 1982. pp. 93-115
  18. 18. Zijlstra EE, El-Hassan AM. Visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2001;95(1):S27-S58
  19. 19. Wilson ME, Streit JA. Visceral leishmaniasis. Gastroenterology Clinics of North America. 1996;25:535-551
  20. 20. Esteves S, Costa I, Amorim C, Santarem N, Cordeiro-da-Silva A. Biomarkers in leishmaniasis: From basic research to clinical application [Internet]. In: Biomarker - Indicator of Abnormal Physiological Process. InTech; 2018. doi: 10.5772/intechopen.75315
  21. 21. Sosa N, Pascale JM, Jiménez AI, Norwood JA, Kreishman-Detrick M, Weina PJ, et al. Topical paromomycin for New World cutaneous leishmaniasis. PLoS Neglected Tropical Diseases. 2019;13(5):e0007253. DOI: 10.1371/journal.pntd.0007253
  22. 22. Mann S, Phupitakphol T, Davis B, Newman S, Suarez JA, Henao-Martínez A, et al. Case report: Cutaneous Leishmaniasis due to Leishmania (Viannia) panamensis in two Travelers successfully treated with Miltefosine. The American Journal of Tropical Medicine and Hygiene. 2020;103(3):1081-1084. DOI: 10.4269/ajtmh.20-0086
  23. 23. Madusanka RK, Hermali S, Nadira DK. Treatment of cutaneous Leishmaniasis and insights into species-specific responses: A narrative review. Infectious Disease and Therapy. 2022;11:695-711. DOI: 10.1007/s40121-022-00602-2
  24. 24. World Health Organization (WHO). Regional Office for Europe. Vector Borne and Rodent Borne Diseases. WHO; 2009. Available from: http://www.euro.who.int/globalchange/Assessment/20070216_10
  25. 25. McDowell MA, Rafati S, Ramalho-Ortigao M, Ben SA. Leishmaniasis: Middle East and North Africa research and development priorities. PLoS Neglected Tropical Diseases. 2011;5:e1219. DOI: 10.1371/journal.pntd.0001219
  26. 26. Tabbabi A, Ghrab J, Aoun K, Ready PD, Bouratbine A. Habitats of the sandfly vectors of Leishmania tropica and L. major in a mixed focus of cutaneous leishmaniasis in south East Tunisia. Acta Tropica. 2011;119:131-137. DOI: 10.1016/j.actatropica.2011.05.002
  27. 27. Tabbabi A, Bousslimi N, Rhim A, Aoun K, Bouratbine A. First report on natural infection of Phlebotomus sergenti with Leishmania promastigotes in the cutaneous leishmaniasis focus in SouthEastern Tunisia. American Journal of Tropical Medicine and Hygiene. 2011;85:646-647. DOI: 10.4269/ajtmh.2011.10-0681
  28. 28. Postigo JA. Leishmaniasis in the World Health Organization eastern Mediterranean region. International Journal of Antimicrobial Agents. 2010;36(Suppl. 1):S62-S65. DOI: 10.1016/j.ijanti micag.2010.06.023
  29. 29. Hamadto HA, Al FA, Farrag AB, Abdel Maksoud MK, Morsy TA. Zoonotic cutaneous leishmaniasis: Reservoir host and insect vector in North Sinai, Egypt. Journal of the Egyptian Society of Parasitology. 2007;37:843-850
  30. 30. Chelbi I, Kaabi B, Béjaoui M, Derbali M, Zhioua E. Spatial correlation between Phlebotomus papatasi Scopoli (Diptera: Psychodidae) and incidence of zoonotic cutaneous leishmaniasis in Tunisia. Journal of Medical Entomology. 2009;46:400-402 PubMed
  31. 31. Harrat Z, Boubidi SC, Pratlong F, Benikhlef R, Selt B, et al. Description of a dermatropic leishmania close to L. killicki (Rioux, Lanotte & Pratlong in Algeria). Transactions of the Royal Society of Tropical Medicine and Hygiene. 2009;103:716-720. DOI: 10.1016/j. trstmh.2009.04.013
  32. 32. Fathy FM, El-Kasah F, El-Ahwal AM. Emerging cutaneous leishmaniasis in Sirte-Libya: Epidemiology, recognition and management. Journal of the Egyptian Society of Parasitology. 2009;39:881905
  33. 33. Lemrani M, Nejjar R, Pratlong F. A new Leishmania tropica zymodeme—Causative agent of canine visceral leishmaniasis in northern Morocco. Annals of Tropical Medicine & Parasitology. 2002;96:637-638. DOI: 10.1179/000349802125001645 PMID: 12396327
  34. 34. Aoun K, Amri F, Chouihi E, et al. killicki en Tunisie: Résultats et analyse de l’identifcation de 226 isolats humains et canins et revue de la littérature. Bulletin de la Societe de Pathologie Exotique. 2008;101:323-328
  35. 35. Aoun K, Jeddi F, Amri F, et al. Actualités épidémiologiques de la leishmaniose viscérale en Tunisie. Médecine et Maladies Infectieuses. 2009;39:775-779. DOI: 10.1016/j.medmal.2009.08.010
  36. 36. Ghrab J, Rhim A, Bach HD, et al. Phlebotominae (Diptera:Psychodidae) of human leishmaniosis sites in Tunisia. Parasite. 2006;13:23-33. DOI: 10.1051/parasite/2006131023
  37. 37. El Idrissi SI, Benlabsir C, Fellah H, Lemrani M, Riyad M. Transmission patterns of Leishmania tropica around the Mediterranean basin: Could Morocco be impacted by a zoonotic spillover? PLOS Neglected Tropical Diseases. 2022;16(1):e0010009. DOI: 10.1371/journal.pntd.0010009
  38. 38. Kbaich MA, Mhaidi I, Ezzahidi A, Dersi N, El Hamouchi A, Riyad M, et al. New epidemiological pattern of cutaneous leishmaniasis in two pre-Saharan arid provinces, southern Morocco. Acta Tropica. 2017;173:11-16. DOI: 10.1016/j.actatropica.2017.05.016. PMID: 28527882
  39. 39. Chaara D, Haouas N, Dedet JP, Babba H, Pratlong F. Leishmaniases in Maghreb: An endemic neglected disease. Acta Tropica. 2014;132:80-93. DOI: 10.1016/j.actatropica.2013.12.018 PMID:24412727
  40. 40. Eddaikra N, Ait-Oudhia K, Kherrachi I, Oury B, Moulti-Mati F, Benikhlef R, et al. Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria. PLoS Neglected Tropical Diseases. 2018;12(3):e0006310. DOI: 10.1371/journal.pntd.0006310. PMID: 29561842
  41. 41. Kassahun A, Sadlova J, Benda P, Kostalova T, Warburg A, Hailu A, et al. Natural infection of bats with Leishmania in Ethiopia. Acta Tropica. 2015;150:166-170. DOI: 10.1016/j.actatropica.2015.07.024 PMID: 26232657
  42. 42. Israël DK, Gonnonta V, Gunter MC, Coulibaliy A, Seydou D. Retrospective study of visceral Leishmaniasis in the Health District of Léré in Chad, Central Africa. Research Square. 2021:1-9. DOI: 10.21203/rs.3.rs-401673/v1
  43. 43. Malaria Consortium. Leishmaniasis control in eastern Africa: Past and present efforts and future needs. Situation and gap analysis. Malaria Consortium. 2010;87. Available from: https://assets.publishing.service.gov.uk/media/57a08b0ae5274a31e0000920/Leishmaniasis_Eastern_Africa_Situation_Analysis.pdf
  44. 44. Alvar J, Bashaye S, Argaw D, Cruz I, Aparicio P, et al. Kala-azaroutbreak in Libo Kemkem, Ethiopia: Epidemiologic and parasitologic assessment. The American Journal of Tropical Medicine and Hygiene. 2007;77:275-282
  45. 45. Leta S, Dao THT, Mesele F, Alemayehu G. Visceral Leishmaniasis in Ethiopia: An evolving disease. PLoS Neglected Tropical Diseases. 2014;8(9):e3131. DOI: 10.1371/journal.pntd.0003131
  46. 46. Dawit G, Girma Z, Simenew K. A review on biology, epidemiology and public health significance of Leishmaniasis. Journal of Bacteriology & Parasitology. 2013;4:166
  47. 47. CDC. Parasites - Leishmaniasis. Centers for Disease Control and Prevention. 2013. Available from: http://www.cdc.gov/parasites/leishmaniasis/ [Accessed: 6 August 2014]
  48. 48. Gebre-Michael T, Lane R. The roles of Phlebotomus martini and P.celiae (Diptera: Phlebotominae) as vectors of visceral leishmaniasis in the aba Roba focus, southern Ethiopia. Medical and Veterinary Entomology. 1996;10:53-62
  49. 49. Gebre-Michael T, Malone JB, Belkew M, Ali A, Berhe N, et al. Mapping the potential distribution of Phlebotomus martini and P.orientalis (Diptera: Psychodidae), vectors of kala-azar in East Africa by use of geographic information systems. Acta Tropica. 2004;90:73-86
  50. 50. Gebre-Michael T, Balkew M, Berhe N, Hailu A, Mekonnen Y. Further studies on the phlebotomine sandflies of the kala-azar endemic lowlands of Humera-Metema (north-West Ethiopia) with observations on their natural blood meal sources. Parasites & Vectors. 2010;3:6
  51. 51. Anjili CO, Ngumbi PM, Kaburi JC, Irungu LW. The phlebotomine sandfly fauna (Diptera: Psychodidae) of Kenya. Journal of Vector Borne Diseases. 2011;48(4):183-189
  52. 52. Al-Salem W, Jennifer RH, Peter JH. A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for east African countries. Parasites & Vectors. 2016;9:460. DOI: 10.1186/s13071-016-1743-7
  53. 53. WHO. Dramatic Upsurge in Visceral Leishmaniasis Cases in the Horn of Africa. Press release; 1998. Available from: http://www.who.int/inf-pr-1998/en/pr98-23.html
  54. 54. Zijlstra EE, Khalil EA, Kager PA, El-Hassan AM. Post-kala-azar dermal leishmaniasis in the Sudan: Clinical presentation and differential diagnosis. The British Journal of Dermatology. 2000;143(1):136-143
  55. 55. Dereure J, El-Safi SH, Bucheton B, Boni M, Kheir MM, Davoust B, et al. Visceral leishmaniasis in eastern Sudan: Parasite identification in humans and dogs; host-parasite relationships. Microbes and Infection. 2003;5(12):1103-1108
  56. 56. Mahdi M, Elamin EM, Melville SE, Musa AM, Blackwell JM, Mukhtar MM, et al. Sudanese mucosal leishmaniasis: Isolation of a parasite within the Leishmania donovani complex that differs genotypically from L. donovani causing classical visceral leishmaniasis. Infection, Genetics and Evolution. 2005;5(1):29-33
  57. 57. Mugasa CM, Deborggraeve S, Schoone GJ, Laurent T, Leeflang MM, Ekangu RA, et al. Accordance and concordance of PCR and NASBA followed by oligochromatography for the molecular diagnosis of Trypanosoma brucei and Leishmania. Tropical Medicine & International Health. 2010;15(7):800-805
  58. 58. Raguenaud ME, Jansson A, Vanlerberghe V, Deborggraeve S, Dujardin JC, Orfanos G, et al. Epidemiology and clinical features of patients with visceral leishmaniasis treated by an MSF clinic in Bakool region, Somalia, 2004-2006. PLoS Neglected Tropical Diseases. 2007;1(1):e85
  59. 59. Marlet MV, Wuillaume F, Jacquet D, Quispe KW, Dujardin JC, Boelaert M. A neglected disease of humans: A new focus of visceral leishmaniasis in Bakool, Somalia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2003;97(6):667-671
  60. 60. Abbasi I, Aramin S, Hailu A, Shiferaw W, Kassahun A, Belay S, et al. Evaluation of PCR procedures for detecting and quantifying Leishmania donovani DNA in large numbers of dried human blood samples from a visceral leishmaniasis focus in northern Ethiopia. BMC Infectious Diseases. 2013;13:153
  61. 61. Gelanew T, Kuhls K, Hurissa Z, Weldegebreal T, Hailu W, Kassahun A, et al. Inference of population structure of Leishmania donovani strains isolated from different Ethiopian visceral leishmaniasis endemic areas. PLoS Neglected Tropical Diseases. 2010;4(11):e889
  62. 62. Wakabi W. Peace has come to southern Sudan, but challenges remain. Lancet. 2006;368(9538):829-830
  63. 63. Desjeux P, Ghosh RS, Dhalaria P, Strub-Wourgaft N, Zijlstra EE. Report of the post kala-azar dermal leishmaniasis (PKDL) consortium meeting, New Delhi, India, 27-29 June 2012. Parasites & Vectors. 2012;6:196
  64. 64. Boakye DA, Wilson MD, Kweku M. A review of leishmaniasis in West Africa. Ghana Medical Journal. 2006;39:94-97
  65. 65. Kimutai A, Peter KN, Willy Kiprotich T, Michael MG, Lydia BN. Leishmaniasis in northern and western Africa: A review. African Journal of Infectious Diseases. 2009;3(1):14-25
  66. 66. Donji B, Dereure J, Poste B, Same-Ekobo A, Dedet JP. Visceral leishmaniasis in Cameroon. Sero-epidemiological survey in the Kousseri region, North Cameroon. Bulletin de la Societe de Pathologie Exotique. 2001;94:418-420
  67. 67. Thierno DM, Develoux M, Ndiaye B, Huerre M. Infiltrated cutaneous leishmaniasis and sporotrichosis caused by Leishmania major. First Senegalese case. Bulletin de la Societe de Pathologie Exotique. 2001;94:19-20
  68. 68. Fryauff JD, Hanafi AH, Klena JD, Hoel DF, Appawu M, Rogers W, et al. Short report: ITS-1 DNA sequence confirmation of Leishmania major as a cause of cutaneous leishmaniasis from an outbreak focus in the Ho district, Southeastern Ghana. The American Journal of Tropical Medicine and Hygiene. 2006;75:502-504
  69. 69. Niamba P, Goumbri-Lompo O, Traoré A, Barro-Traoré F, Soudré RT. Diffuse cutaneous leishmaniasis in an HIV-positive patient in western Africa. The Australasian Journal of Dermatology. 2007;48:32-34
  70. 70. Ghatee MA, Taylor WR, Karamian M. The geographical distribution of cutaneous Leishmaniasis causative agents in Iran and its Neighboring countries, a review. Frontiers in Public Health. 2020;18:8-11. DOI: 10.3389/fpubh.2020.00011 PMID: 32133334
  71. 71. Alawieh A, Musharrafieh U, Jaber A, Berry A, Ghosn N, Bizri AR. Revisiting leishmaniasis in the time of war: The Syrian conflict and the Lebanese outbreak. International Journal of Infectious Diseases. 2014;29:115-119. https://doi.org/10.1016/j.ijid.2014.04.023 PMID: 25449245
  72. 72. Saroufim M, Charafeddine K, Issa G, Khalifeh H, Habib RH, Berry A, et al. Ongoing epidemic of cutaneous leishmaniasis among Syrian refugees, Lebanon. Emerging Infectious Diseases. 2014;20:1712-1715. DOI: 10.3201/eid2010.140288 PMID: 25279543
  73. 73. Kamhawi S, Modi GB, Pimenta PFP, Rowton E, Sacks DL. The vectorial competence of Phlebotomus sergenti is specific for Leishmania tropica and is controlled by species-specific, lipophosphoglycanmediated midgut attachment. Parasitology. 2000;121:25-33. DOI: 10.1017/s0031182099006125 PMID:11085222
  74. 74. Depaquit J, Ferté H, Léger N, Lefranc F, Alves-Pires C, Hanafi H, et al. ITS2 sequences heterogeneity in Phlebotomus sergenti and Phlebotomus similis (Diptera, Psychodidae): Possible consequences in their ability to transmit Leishmania tropica. International Journal for Parasitology. 2002;32:1123-1131. DOI: 10.1016/s0020-7519(02)00088-7 PMID:12117495
  75. 75. Maroli M, Feliciangeli MD, Bichaud L, Charrel RN, Gradoni L. Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern. Medical and Veterinary Entomology. 2013;27:123-147. DOI: 10.1111/j.1365-2915.2012.01034.x PMID: 22924419
  76. 76. Wasserberg G, Abramsky Z, Kotler BP, Ostfeld RS, Yarom I, Warburg A. Anthropogenic disturbances enhance occurrence of cutaneous leishmaniasis in Israel deserts: Patterns and mechanisms. Ecological Applications. 2003;13(3):868-881
  77. 77. Shiravand B, Hanafi-Bojd AA, Tafti AAD, Abai MR, Almodarresi A, Mirzaei M. Climate change and potential distribution of zoonotic cutaneous leishmaniasis in Central Iran: Horizon 2030 and 2050. Asian Pacific Journal of Tropical Medicine. 2019;12(5):204-215
  78. 78. Schnur LF, Nasereddin A, Eisenberger CL, Jaffe CL, El Fari M, Azmi K, et al. Multifarious characterization of Leishmania tropica from a Judean desert focus, exposing intraspecific diversity and incriminating Phlebotomus sergenti as its vector. The American Journal of Tropical Medicine and Hygiene. 2004;70:364-372. DOI: 10.4269/ajtmh.2004.70.364
  79. 79. Farash BRH, Shamsian SAA, Mohajery M, Fata A, Sadabadi F, Berenji F, et al. Changes in the epidemiology of cutaneous Leishmaniasis in northern Iran. Türkiye Parazitolojii Dergisi. 2020;44(1):52-57
  80. 80. Mondragon-Shem K, Al-Salem WS, Kelly-Hope L, Abdeladhim M, Al-Zahrani MH, Valenzuela JG, et al. Severity of old world cutaneous leishmaniasis is influenced by previous exposure to sandfly bites in Saudi Arabia. PLoS Neglected Tropical Diseases. 2015;9:e0003449. DOI: 10.1371/journal.pntd.0003449
  81. 81. El-Beshbishy HA, Al-Ali KH, El-Badry AA. Molecular characterization of cutaneous leishmaniasis in Al-Madinah Al-Munawarah province, western Saudi Arabia. International Journal of Infectious Diseases. 2013;17:e334-e338. DOI: 10.1016/j.ijid.2012.11.015 92
  82. 82. Haouas N, Amer O, Alshammri FF, Al-Shammari S, Remadi L, Ashankyty I. Cutaneous leishmaniasis in northwestern Saudi Arabia: Identification of sand fly fauna and parasites. Parasites & Vectors. 2017;10:544. DOI: 10.1186/s13071-017-2497-6
  83. 83. Zakai HA. Cutaneous leishmaniasis in Saudi Arabia: current status. Journal of Advanced Laboratory Research in Biology. 2014;5:29-34
  84. 84. Salam N, Al-Shaqha WM, Azzi A. Leishmaniasis in the Middle East: Incidence and epidemiology. PLoS Neglected Tropical Diseases. 2014;8:e3208. DOI: 10.1371/journal.pntd.0003208
  85. 85. Ali MA, Rahi AA, Khamesipour A. Species typing with PCR–RFLP from cutaneous leishmaniasis patients in Iraq. Donnish Journal of Medicine and Medical Sciences. 2015;2:026-031
  86. 86. Al-Bajalan MM, Al-Jaf SM, Niranji SS, Abdulkareem DR, Al-Kayali KK, Kato H. An outbreak of Leishmania major from an endemic to a non-endemic region posed a public health threat in Iraq from 2014-2017: Epidemiological, molecular and phylogenetic studies. PLoS Neglected Tropical Diseases. 2018;12:e0006255. DOI: 10.1371/journal.pntd.0006255
  87. 87. Hajra H, Nazar-ul I, Khalid M, Sajid A. Occurrence analysis of cutaneous Leishmaniasis particularly in Pakistan. Biomedical Journal of Scientific & Technical Research. 2019;19(5):1-5. BJSTR.MS.ID.003359
  88. 88. Hussain M, Munir S, Ayaz S, Khattak BU, Khan TA, Muhammad N, et al. First report on molecular characterization of Leishmania species from cutaneous leishmaniasis patients in southern Khyber Pakhtunkhwa province of Pakistan. Asian Pacific Journal of Tropical Medicine. 2017;10:718-721. DOI: 10.1016/j.apjtm.2017.07.015
  89. 89. Ghatee MA, Sharifi I, Kuhls K, Kanannejad Z, Harandi MF, de Almeida ME, et al. Heterogeneity of the internal transcribed spacer region in Leishmania tropica isolates from southern Iran. Experimental Parasitology. 2014;144:44-51. DOI: 10.1016/j.exppara.2014.06.003
  90. 90. Naseer U, Muzafar S, Mian SKA. Brief review on infestation of cutaneous Leishmaniasis in Pakistan. Biomedical Journal of Scientific & Technical Research. 2020;31(4):1-4. BJSTR.MS.ID.005141
  91. 91. Fakhar M, Karamian M, Ghatee MA, Taylor WR, Ghohe HP, Rasooli SA. Distribution pattern of anthroponotic cutaneous leishmaniasis caused by Leishmania tropica in Western Afghanistan during 2013-2014. Acta Tropica. 2017;176:22-28. DOI: 10.1016/j.actatropica.2017.07.028
  92. 92. Ready PD. Leishmaniasis emergence in Europe. Euro Surveillance. 2010;15(10):29-39. DOI: 10.2807/ese.15.10.19505-en PMID: 20403308
  93. 93. Fotakis EA, Giantsis IA, Avgerinou A, Kourtidis S, Agathaggelidou E, Kapoula C, et al. Identification of Leishmania species in naturally infected sand flies from refugee camps, Greece. Emerging Infectious Diseases. 2019;25:361-364. DOI: 10.3201/eid2502.181359 PMID: 30346269
  94. 94. Gramiccia M, Gradoni L. The leishmaniases in southern Europe. In: Takken W, Knols BGJ, editors. Emerging Pests and Vector-Borne Diseases, Ecology and Control of Vector Borne Diseases. Vol. 1. Wageningen Academic Publishers; 2007. pp. 75-95
  95. 95. Ready PD. Leishmaniasis emergence and climate change. In: de la Roque S, editor. Climate Change: The Impact on the Epidemiology and Control of Animal Diseases. Rev Sci Tech Off Int Epiz. Vol. 27, No. 2. 2008. pp. 399-412. doi: 10.20506/rst.27.2.1803
  96. 96. Van der Auwera G, Davidsson L, Buffet P, Ruf MT, Gramiccia M, Varani S, et al. LeishMan surveillance network. Surveillance of leishmaniasis cases from 15 European centres, 2014 to 2019: A retrospective analysis. Euro Surveillance. 2022;27(4):2002028. DOI: 10.2807/15607917.ES.2022.27.4.200202
  97. 97. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, et al. Cutaneous leishmaniasis. The Lancet Infectious Diseases. 2007;7:581-596
  98. 98. González C, Wang O, Strutz SE, González-Salazar C, Sánchez-Cordero V, et al. Climate change and risk of Leishmaniasis in North America: Predictions from ecological niche models of vector and reservoir species. PLoS Neglected Tropical Diseases. 2010;4(1):e585. DOI: 10.1371/journal.pntd.0000585
  99. 99. Curtin JM, Aronson NE. Leishmaniasis in the United States: Emerging issues in a region of low Endemicity. Microorganisms. 2021;9:578. DOI: 10.3390/microorganisms9030578
  100. 100. Arumugam S, Scorza BM, Petersen C. Visceral Leishmaniasis and the skin: Dermal parasite transmission to sand flies. Pathogens. 2022;11:610. DOI: 10.3390/pathogens11060610
  101. 101. Germanó M, Salomón MC, Neira G, Lozano E, Mackern-Oberti JP, Cargnelutti DE. Leishmaniasis in Argentine Republic: Temporal and geographical distribution from 2013 to 2017. Asian Pacific Journal of Tropical Medicine. 2019;12(7):300-305
  102. 102. Salomon OD, Quintana MG, Rosa JR. Eco-epidemiologia de leishmaniasis cutanea en Argentina. Sociedad Iberoamericana de Informacion Científica (SIICSALUD) Salud (i) Ciencia. 2008;16(5):514-520
  103. 103. Hammami-Ghorbel H, Bem AI, Badri T, Chelbi H, Fenniche S, et al. Mucosal leishmaniasis of the lip: An emerging clinical form in Tunisia. Journal of the European Academy of Dermatology and Venereology. 2015;29:1212-1215
  104. 104. Miguel DC, Guarnier DC. Canine and human Leishmaniasis: Disease progression to Brazilian urbanized areas. International Journal of Tropical Diseases. 2019;2:023
  105. 105. Joao GG, Luz J, Victor LD, Amanda GC, Paulo AP, Juliana HC, et al. Human visceral leishmaniasis in Central-Western Brazil: Spatial patterns and its correlation with socioeconomic aspects, environmental indices and canine infection. Acta Tropica. 2021;221:105965
  106. 106. Simão JC, Victória C, Fortaleza CMCB. Factors Affectng the spatial distribution of visceral Leishmaniasis in an urban area of recent emergence in inner Brazil. International Journal of Tropical Diseases. 2021;4:051. DOI: 10.23937/2643-461X/1710051
  107. 107. Portella TP, Kraenkel RA. Spatial–temporal pattern of cutaneous leishmaniasis in Brazil. Infectious Diseases of Poverty. 2021;10:86. DOI: 10.1186/s40249-021-00872-x
  108. 108. Filipe DT. Canine leishmaniosis in South America. Parasites & Vectors. 2009;2(1):S1. DOI: 10.1186/1756-3305-2-S1-S1
  109. 109. Ramírez JD, Carolina H, Cielo ML, Martha SA, Carolina F, Camila G. Taxonomy, diversity, temporal and geographical distribution of cutaneous Leishmaniasis in Colombia: A retrospective study. Scientific Reports 2019;6:28266. doi: 10.1038/srep28266
  110. 110. Salgado-Almario J, Hernández CA, Ovalle CE. Geographical distribution of Leishmania species in Colombia, 1985-2017. Biomédica. 2016;39:278-290. DOI: 10.7705/biomedica.v39i3.4312
  111. 111. Copa GN, María CA, Lorena VA, Alejandro JK, Silvana PC, Marisa J, et al. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2019;113:91-100. DOI: 10.1093/trstmh/try113
  112. 112. Anjalie A, Susiji WA. Comprehensive review of cutaneous Leishmaniasis in Sri Lanka and Identifcation of existing knowledge gaps. Acta Parasitologica. 2020;65:300-309. DOI: 10.2478/s11686-020-00174-6
  113. 113. Adhikari RC, Shah M. Cutaneous leishmaniasis. Journal of Pathology of Nepal. 2017;7:1212-1217. DOI: 10.3126/jpn.v7i2.18031
  114. 114. Ahammed A, Feroz S, Bhattacharyya B, Ahammed I, Selim S, Yusuf MA, et al. Living pattern and behavioural risk factors for kala azar: A case-control study in tertiary care hospital of Bangladesh. Bangladesh Journal of Infectious Diseases. 2016;3(2):29-35
  115. 115. Abdullah AY, Ashraf D, Rakibul IS, Masudur R, Faruk H. Environmental factors associated with the distribution of visceral leishmaniasis in endemic areas of Bangladesh: Modelling the ecological niche. Tropical Medicine and Health. 2017;45:13. DOI: 10.1186/s41182-017-0054-9
  116. 116. Alan JM, Wayne MM, Mary KKF, Ronald CN. Visceral Leishmaniasis. Standard Form 298 (Rev. 8-98) Prescribed by ANSI Std Z39-18
  117. 117. Ghosh P, Roy P, Chaudhuri S, Das N. Epidemiology of post-kala-azar dermal leishmaniasis. Indian Journal of Dermatology. 2021;6(1):12. Available from: link.gale.com/apps/doc/A651095875/AONE?u=googlescholar&sid=googleScholar&xid=604c1edc. [Accessed: 24 July 2022]
  118. 118. WHO. 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis
  119. 119. Tangie LN, Desmond A, Aminde LN, Annabel MA, Halle PM. Cutaneous leishmaniasis in a severelyimmunocompromised HIV patient in Kumbo, northwest region of Cameroon: Case report. BMC Research Notes. 2017;10:425. DOI: 10.1186/s13104-017-2751-1
  120. 120. Cloots K, Marino P, Burza S, Gill N, Boelaert M, Hasker E. Visceral Leishmaniasis-HIV coinfection as a predictor of increased Leishmania transmission at the village level in Bihar, India. Frontiers in Cellular and Infection Microbiology. 2021;11:604117. DOI: 10.3389/fcimb.2021.604117
  121. 121. Lindoso JAL, Moreira CHV, Cunha MA, Queiroz IT. Visceral leishmaniasis and HIV coinfection: Current perspectives. Dovepress. HIV/AIDS - Research and Palliative Care. 2018;10:193-201. DOI: 10.2147/HIV.S143929
  122. 122. Naveen SS, Doris PS. A review on major risk factors and current status of visceral Leishmaniasis in North India. American Journal of Entomology. 2019;3(1):6-14. DOI: 10.11648/j.aje.20190301.12
  123. 123. Bhunia GS, Kumar V, Kumar AJ, Das P, Kesari S. The use of remote sensing in the identification of the eco-environmental factors associated with the risk of human visceral leishmaniasis (kala-azar) on the Gangetic plain, in North-Eastern India. Annals of Tropical Medicine and Parasitology. 2010;104:35-53
  124. 124. Parmesan C. Ecological and evolutionary responses to recent climate change. Annual Review of Ecology, Evolution, and Systematics. 2006;37:637-669
  125. 125. Oryan A, Akbari M. Worldwide risk factors in leishmaniasis. Asian Pacific Journal of Tropical Medicine. 2016;9(10):925-932
  126. 126. Araujo AR, Portela NC, Feitosa APS, Silva OA, Ximenes RAA, Alves LC, et al. Risk factors associated with American cutaneous leishmaniasis in an endemic area of Brazil. Revista do Instituto de Medicina Tropical de São Paulo. 2016;58:86
  127. 127. Terefe Y, Afera B, Bsrat A, Syoum Z. Distribution of human leishmaniasis (VL) and its associated risk factors, in Metemma, Ethiopia. Epidemiology Research International. 2015:5. Article ID 630812. doi: 10.1155/2015/630812
  128. 128. Mandal PK, Wagle RR, Uranw S, Thakur AK. Risk factors for visceral leishmaniasis in selected high endemic areas of Morang, Nepal: A case control study. Journal of Kathmandu Medical College. 2020;9(4):188-196. DOI: 10.3126/jkmc.v9i4.36406
  129. 129. Saha S, Ramachandran R, Hutin YJF, Mohan D, Gupte MD. Visceral leishmaniasis is preventable in a highly endemic village in West Bengal, India. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2009;103:737-742
  130. 130. Bamorovat M, Sharifi I, Aflatoonian MR, Sharifi H, Karamoozian A, Sharifi F, et al. Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran. PLoS One. 2018;13:e0192236. DOI: 10.1371/journal.pone.0192236
  131. 131. Bamorovat M, Sharifi I, Aflatoonian MR, Sadeghi B, Shafiian A, Oliaee RT, et al. Host’s immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways. International Immunopharmacology. 2019a;69:321-327. doi: 10.1016/j.intimp.2019.02.008
  132. 132. Kiptui EG, Sabella JK, Gladys JM. Risk factors of visceral leishmaniasis among residents of Baringo County, Kenya. International Journal of Community Medicine and Public Health. 2021;8(11):5251-5257. DOI: 10.18203/2394-6040.ijcmph20214257
  133. 133. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in Leishmaniasis. Lancet. 2005;366:1561-1577
  134. 134. El Aasri A, Nizar S, Youssef El M, rutKhadija El K, Driss B. Sand flies (Diptera: Psychodidae) vectors of Leishmania: Notes on five species captured in Bni Oual locality, North-Western Morocco. Entomologie Faunistique – Faunistic Entomology. 2018;71:1-7
  135. 135. Martínez DC, Ávila JL, Molano F. Sandfly (Diptera: Psychodidae: Phlebotominae) present in an endemic area of cutaneous leishmaniasis in West Boyacá, Colombia. Colombia Médica (Cali, Colombia). 2019;50(3):192-200. DOI: 1025100/cm.v50i3.3051
  136. 136. Nawaz S, Irum S, Ahmed H, Shamas S, Roshan S, Raf MA, et al. Phlebotominae sandflies distribution and incidence of leishmaniasis from selected areas of Punjab Province, Pakistan. Punjab University Journal of Zoology. 2020;35(2):173-177. DOI: 10.17582/journal.pujz/2020.35.2.173.177
  137. 137. Limoncu M, Emin İ, Cüneyt B, Seray T, Samiye D, Hakan K, et al. Entomological survey for the detection of sand Fly Fauna and Vector species in the cutaneous Leishmaniasis endemic area in East Mediterranean region of Turkey, Mersin Province. Journal of Medical Entomology. 2020;57(5):1510-1515. DOI: 10.1093/jme/tjaa089
  138. 138. Pereira NCL, Érika MM, Fabiana OLS, Rosana SL, Adão JVP, Daniele MP, et al. Ecology of phlebotomine sand flies in a Brazilian area with recent leishmaniasis transmission (Itaúna, in Minas Gerais state). Journal of the Brazilian Society of Tropical Medicine. 2020;53:e20190538. DOI: 10.1590/0037-8682-2019-0538-2019
  139. 139. Edna DD, Godwin KN, Seth OA, Alexander EY. Identification of sand flies (Diptera: Psychodidae) collected from cutaneous Leishmaniasis endemic focus in the Ho municipality, Ghana. Annals of Science. 2021;10(1):33-44. DOI: 10.21467/ias.10.1.33-44
  140. 140. Al-Koleeby Z, Ahmed El A, Chafika F. Seasonal Changes of sandflies: A study of the Endemic Outbreak of Leishmania Major in Zagora, Southeast Morocco. E3S Web of Conferences. Vol. 234. 2021. p. 00104. DOI: 10.1051/e3sconf/202123400104
  141. 141. Vadmal G, Caroline KG, Barbara AH, Bruno C, Adrian AC, Erin AM. Data-driven predictions of potential Leishmania vectors in Latin America. bioRxiv, The Preprint Server for Biology. 1-41. DOI: 10.1101/2022.08.22.504897
  142. 142. Mahendra P, Iyasu E, Adugna G, Kushagra D, Pratibha D. Etiology, clinical Spectrum, epidemiology, diagnosis, public health significance and control of Leishmaniasis: A Compre-hensive review. Acta Scientific Microbiology. 2022;5(5):140-151. DOI: 10.31080/ASMI.2022.05.1066
  143. 143. Umi A, Yudha N. New World Leishmania more Severe than Old World Leishmania: New World Species Cause a Spectrum of Disease Ranging from Mild Cutaneous Disease to Severe Mucosal Lesions. Research Gate; 2017. Available from: https://www.researchgate.net/publication/321422269
  144. 144. Ondriska F, Bukovinova P, Votypka J, Nohynkova E, Boldis V. Imported new world cutaneous leishmaniasis in a traveller from Slovakia. Bratislavské Lekárske Listy. 2015;116(3):203-206. DOI: 10.4149/BLL_2015_040

Written By

Stephen Kyari

Submitted: 15 August 2022 Reviewed: 12 February 2023 Published: 24 April 2024